The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: A report from the SHOCK Trial Registry

Journal of the American College of Cardiology

Volumn 36, Issue 3 SUPPL. A, 2000, Pages 1071-1076

  Menon, Venu ^a,f   White, Harvey ^b   LeJemtel, Thierry ^c   Webb, John G ^d   Sleeper, Lynn A ^e   Hochman, Judith S ^a  

^a Howard Hughes Medical Institute   (United States)

^b GREEN LANE HOSPITAL   (New Zealand)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d ST PAUL S HOSPITAL   (Canada)

^e NEW ENGLAND RESEARCH INSTITUTES   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYTIC THERAPY; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HUMAN; KIDNEY FAILURE; LUNG CAPILLARY PRESSURE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; HYPOTENSION; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; PULMONARY WEDGE PRESSURE; REGISTRIES; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY; VASOCONSTRICTOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033867499     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00874-3     Document Type: Article

References (26)

1. Quantitative study of infarcted myocardium in cardiogenic shock
2. Myocardial changes associated with cardiogenic shock
3. Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical pathologic and electrocardiographic correlations
4. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction
5. Frequency of inclusion of patients with cardiogenic shock in trials of thrombolytic therapy
6. Controlled trial of streptokinase and heparin in acute myocardial infarction
7. In-hospital mortality and clinical course of 20,981 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase without heparin
8. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
9. Effectiveness of intravenous thrombolytic therapy in acute myocardial infarction
10. A comparison of reteplase with alteplase for acute myocardial infarction
11. Should we emergently revascularize occluded coronary arteries for cardiogenic shock: An international randomized trial of emergency PTCA/CABG: Trial Design
12. Early revascularization in acute myocardial infarction complicated by cardiogenic shock
13. Cardiogenic shock complicating acute myocardial infarction - Etiologies, management and outcome: A report from the SHOCK Trial Registry
14. Hemodynamic spectrum of myocardial infarction and cardiogenic shock: A conceptual model
15. Mitral stenosis and pulmonary fibrosis. Special reference to pulmonary edema and lung lymphatic function
16. Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man
17. Early sequential changes in left ventricular dimensions and filling pressures in patients after myocardial infarction
18. Right ventricular infarction complicated by cardiogenic shock: Observations and implications. The NHLBI SHOCK Registry
19. Correlative classification of clinical and hemodynamic function after acute myocardial infarction
20. Cardiogenic shock complicating acute myocardial infarction: Predictors of death. GUSTO Investigators
21. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: Report of the SHOCK Trial registry
22. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients
23. Medical therapy of acute myocardial infarction by application of hemodynamic subsets
24. Lack of progress in cardiogenic shock. Lessons from the GUSTO Trials
25. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators